Īlthough most evidence has been on the negative mental health impacts of COVID-19, a parallel area of research interest has explored how mental health services change when exposed to such stressors. Furthermore, emerging reports suggested the possibility of the long-term effects of pandemics on psychological well-being. Increased symptoms of mental health disorders and limited access to mental health care services and social support have also been reported in people with preexisting mental health disorders. In a cross-sectional study by Lai et al in China, 50% (634/1257) of health care workers reported experiencing depressive symptoms 45% (560/1257) had anxiety and 34% (427/1257) reported experiencing insomnia.
These risk factors might result in mental health problems, such as anxiety, depression, and insomnia, particularly in susceptible populations that include patients with COVID-19, first-line health professionals, and older adults. Social isolation, loneliness, unemployment, and loss of income after the incidence of COVID-19 have become common. Fear of the virus and containment strategies might challenge psychological well-being. After the rapid spread of the novel SARS-CoV-2, known risk factors for mental health impacts have been reported worldwide. The results of the meta-analysis showed that digital mental health interventions were associated with a small reduction in depressive symptoms (standardized mean difference=−0.49 95% CI −0.74 to −0.24 P<.001) and a moderate reduction in anxiety symptoms (standardized mean difference=−0.66 95% CI −1.23 to −1.0 P=.02) significantly.Īs of October 5, 2022, there were 624.4 million confirmed cases of COVID-19 spread over 228 countries and territories, and COVID-19 has claimed the lives of 6.6 million individuals. Psychotherapy (44/65, 67.7%) followed by psychoeducation (6/65, 9.2%) and psychological support (5/65, 7.7%) were commonly used. A total of 15 (23.1%) studies measured the usability 31 (47.7%) studies evaluated the feasibility 29 (44.6%) studies assessed the acceptability and 51 (78.5%) studies assessed the efficacy. Of the 65 studies, 16 (24.6%) were included in the meta-analysis. In total, 65 (0.9%) studies from 18 countries with 67,884 participants were eligible for the scoping review.
This review identified 7506 articles through database searching.
0 kommentar(er)
